Barban Plus Tablets 80/12.5 mg

Adult dose

The recommended dosage is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily, to be taken with a small amount of water regardless of meals. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is applicable if prescribed. For patients with renal impairment classified as mild to moderate (creatinine clearance greater than 30 mL/min), dosage adjustment is not required. For patients with liver impairment, mild to moderate without cholestasis should not exceed 80 mg of valsartan daily.

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any component of this medication or sulfonamide drugs, severe liver disease, kidney disease, or certain blood disorders should not use this medication. Caution should be exercised when using this medication in cases of electrolyte imbalance, impaired liver or kidney function, autoimmune diseases, the elderly, and patients with heart disease, and regular check-ups are necessary. The hydrochlorothiazide component can increase the risk of skin cancer due to sensitivity to sunlight; therefore, it is important to limit sun exposure and regularly check skin condition. This medication can cause dizziness or drowsiness, so care should be taken when driving or operating machinery. Potassium supplements or potassium-containing medications should not be taken without consulting a doctor, and if symptoms of hypotension occur due to blood pressure reduction, medical personnel should be informed immediately. During the use of this medication, regular blood tests to check electrolytes, kidney, and liver function are necessary. When used in combination with other medications, interactions may occur, so consultation with a doctor or pharmacist is essential, especially regarding lithium, NSAIDs, and other blood pressure medications. It is preferable for pregnant and breastfeeding women not to use this medication, and if exposure occurs during pregnancy, the condition of the fetus and newborn should be closely monitored. Safety in children has not been established, so it is not used in pediatric patients. In case of overdose, there is a risk of hypotension, electrolyte abnormalities, renal failure, etc., so immediate medical attention should be sought for appropriate treatment. This medication should be stored out of the reach of children and kept in its original container to avoid moisture.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Headache
• dizziness
• rhinitis
• fatigue
• back pain
• cough
• upper respiratory tract infection
• diarrhea
• joint pain
• abdominal pain

This medication should be stored in a tightly sealed container to protect it from air or moisture. Additionally, it should be kept in a cool place below 30 degrees Celsius to preserve its efficacy.

Appearance

Bright pink oval film-coated tablets

Package unit

30 tablets/bottle